Email
IZ Express #1,692: FDA approves first RSV vaccine for adults age 60+, and more
| From | Immunize.org <[email protected]> |
| Subject | IZ Express #1,692: FDA approves first RSV vaccine for adults age 60+, and more |
| Date | May 10, 2023 10:01 AM |
Links have been removed from this email. Learn more in the FAQ.
Links have been removed from this email. Learn more in the FAQ.
[link removed] [link removed] [link removed] [link removed] [link removed]
Email not displaying correctly? View it in your browser. ([link removed])
[link removed]
Issue 1,692: May 10, 2023
Top Stories
* FDA approves first respiratory syncytial virus (RSV) vaccine for people age 60 and older; ACIP will consider recommendations for its use in future meetings (#IZX1)
* Immunize.org updates its "Checklist of Current Versions of U.S. COVID-19 Vaccination Guidance and Clinic Support Tools" (#IZX2)
* Mother’s Day is May 14; thanks to all the moms who give babies a healthy start with recommended vaccinations (#IZX3)
* 2023 Dr. Maurice R. Hilleman Essay Contest: Encourage students in grades 6–12 to enter (#IZX4)
* Immunize.org's Influenza Vaccination Honor Roll for mandatory healthcare worker vaccination now features 1,300 organizations, including two new facilities (#IZX5)
* Spotlight: Immunize.org resources focused on communication between healthcare personnel and patients or caregivers (#IZX6)
* Vaccines in the news (#IZX7)
Immunize.org Pages and Handouts
* Immunize.org updates seven translations of “Vaccinations for Preteens and Teens” and “Vaccinations for Adults” (#IZX8)
Featured Resources
* NFID posts new podcast episode featuring Katherine L. O’Brien, MD, MPH, on bringing communities around the world up to date on vaccinations (#IZX9)
* Voices for Vaccines releases podcast with Dorit Reiss, PhD, to discuss anti-vaccine litigation (#IZX10)
* While supplies last! Laminated versions of CDC’s 2023 immunization schedules still available. (#IZX11)
* Order Immunize.org’s child, adult, and lifetime immunization record cards—wallet-sized, designed to last! (#IZX12)
Notable Publications
* "COVID-19 Mortality Update—United States, 2022" published in MMWR (#IZX13)
Upcoming Events
* Virtual: NFID hosts webinar titled “Shingles Prevention through Vaccination” on May 17 (#IZX14)
Editorial Information (#Editorial)
------------------------------------------------------------
Top Stories
------------------------------------------------------------
FDA approves first respiratory syncytial virus (RSV) vaccine for people age 60 and older; ACIP will consider recommendations for its use in future meetings
According to CDC ([link removed]) , each year in the United States respiratory syncytial virus (RSV) leads to approximately 60,000–120,000 hospitalizations and 6,000–10,000 deaths among adults age 65 and older. Like influenza, RSV is a seasonal virus, with peak activity typically occurring each fall or winter. On May 30, FDA approved the first vaccine to prevent RSV, to be distributed with the brand name Arexvy (manufactured by GSK). Arexvy is approved for preventing lower respiratory tract disease (LRTD) caused by RSV in individuals age 60 and older. The next step on the vaccine’s path to clinical implementation is for CDC's Advisory Committee on Immunization Practices (ACIP) to consider recommendations for the vaccine's use at its next meeting. A portion of the FDA press release ([link removed]) appears below.
The safety and effectiveness of Arexvy is based on the FDA’s analysis of data from an ongoing, randomized, placebo-controlled clinical study conducted in the U.S. and internationally in individuals 60 years of age and older. The main clinical study of Arexvy was designed to assess the safety and effectiveness of a single dose administered to individuals 60 years of age and older. Participants will remain in the study through three RSV seasons to assess the duration of effectiveness and the safety and effectiveness of repeat vaccination. Data for a single dose of Arexvy from the first RSV season of the study were available for the FDA’s analysis. . . .
Among the participants who have received Arexvy and the participants who have received a placebo, the vaccine significantly reduced the risk of developing RSV-associated LRTD by 82.6% and reduced the risk of developing severe RSV-associated LRTD by 94.1%. . . . the most commonly reported side effects by individuals who received Arexvy were injection site pain, fatigue, muscle pain, headache and joint stiffness/pain.
Related Links
* FDA: FDA Approves First Respiratory Syncytial Virus (RSV) Vaccine ([link removed]) press release (5/3/23)
* FDA: Arexvy product approval letter ([link removed]) (5/3/23)
* FDA: Arexvy ([link removed]) web page
* FDA: Arexvy Package Insert ([link removed])
Back to top (#Top)
------------------------------------------------------------
Immunize.org updates its "Checklist of Current Versions of U.S. COVID-19 Vaccination Guidance and Clinic Support Tools"
Immunize.org reviews and updates the Checklist of Current Versions of U.S. COVID-19 Vaccination Guidance and Clinic Support Tools ([link removed]) every month, prominently indicating when it was last updated at the top of the page. In accordance with recent CDC and FDA changes to COVID-19 vaccine use and availability, the checklist has been modified as follows:
* All references to monovalent mRNA (Pfizer-BioNTech and Moderna) vaccine formulations have been removed, including all FDA and CDC materials for monovalent products
* Links to CDC clinical materials have been updated as they were available at the time of the checklist’s publication. Updates to a few clinical materials are still in process.
* Janssen COVID-19 Vaccine (Johnson & Johnson) is no longer included on the checklist. All remaining doses of this vaccine have expired.
All COVID-19 vaccination providers should review the checklist regularly. The checklist is posted on Immunize.org's Vaccines: COVID-19 ([link removed]) main page to help practices stay up to date.
[link removed]
Related Links
* Immunize.org: Checklist of Current Versions of U.S. COVID-19 Vaccination Guidance and Clinic Support Tools ([link removed]) (PDF)
* Immunize.org: Vaccines: COVID-19 ([link removed]) main page
* Immunize.org: Ask the Experts: COVID-19 ([link removed]) web page
* CDC: Interim Clinical Considerations ([link removed]) main page summarizing use of COVID-19 vaccines in the United States
Back to top (#Top)
------------------------------------------------------------
Mother’s Day is May 14; thanks to all the moms who give babies a healthy start with recommended vaccinations
Mother's Day is Sunday, May 14, this year. Immunize.org celebrates mothers and mothers-to-be and all they do to give their children a healthy start in life. Protecting babies through vaccination begins during pregnancy. Receiving influenza, Tdap, and COVID-19 vaccines during pregnancy ([link removed]) protects the mother and delivers protective antibodies through the placenta from mom to baby, providing protection through the first few months of life. CDC, the American College of Obstetrics and Gynecology ([link removed]) (ACOG) and other experts recommend these three vaccines during pregnancy.
[link removed]
Tdap is needed during each pregnancy, preferably between 27 and 36 weeks of gestation. Tdap helps protect against whooping cough (pertussis), which can be life-threatening for newborns, as well as neonatal tetanus and diphtheria.
People who get influenza or COVID-19 infections while pregnant face an increased risk of hospitalization and complications, compared to their nonpregnant peers. Getting influenza vaccine during each pregnancy helps protect mother and baby from influenza. COVID-19 vaccination should be given during pregnancy whenever it is due. Both vaccines are well-studied and safe at any stage of pregnancy. Vaccines given during pregnancy help protect mother and baby from serious complications and death.
Thank you to all the moms who work hard to safeguard the health and well-being of their children every day. Immunize.org wishes all mothers a happy Mother's Day!
Related Links
* CDC: Pregnancy and Vaccination ([link removed] ) main page
* CHOP VEC: Vaccines and Your Baby ([link removed]) booklet (view in Spanish ([link removed]) )
* Immunize.org: Handouts: Pregnancy and Vaccines ([link removed]) main page
* Immunize.org: Screening Checklists about Vaccine Contraindications and Precautions ([link removed]) main page
* Immunize.org: CDC Schedules ([link removed]) main page
Back to top (#Top)
------------------------------------------------------------
2023 Dr. Maurice R. Hilleman Essay Contest: Encourage students in grades 6–12 to enter
The Vaccine Makers Project ([link removed]) , the classroom-based program of the Vaccine Education Center (VEC) at Children’s Hospital of Philadelphia, invites submissions for the 2023 Maurice R. Hilleman Essay Contest ([link removed]) . Students in grades 6 through 12 are encouraged to learn about Dr. Hilleman’s life and accomplishments and submit a 500- to 600-word essay by June 9, 2023. This year's writing prompt is "Preparedness is an important component of science as demonstrated by Maurice Hilleman when he identified the 1957 influenza pandemic. How is preparedness critical in science today?"
This year VEC partnered with Public Health Association of British Columbia ([link removed]) , Kids Boost Immunity ([link removed]) , and Frontline Immunity ([link removed]) to open the Maurice R. Hilleman Essay Contest to Canadian students.
[link removed]
Details and the entry form are available at HillemanFilm.com/contest ([link removed]) . This year there will be three winners. The winners will each receive $500, a certificate, and recognition at a virtual award event this fall. Please share this information with eligible students or with teachers who may be interested in sharing with their students.
Related Links
* The Vaccine Makers Project ([link removed]) website
* VEC: Hilleman Film ([link removed]) website
Back to top (#Top)
------------------------------------------------------------
Immunize.org's Influenza Vaccination Honor Roll for mandatory healthcare worker vaccination now features 1,300 organizations, including two new facilities
Immunize.org's Influenza Vaccination Honor Roll ([link removed]) recognizes facilities that take a stand for patient safety by implementing policies for mandatory healthcare personnel influenza vaccination. There are now 1,300 organizations enrolled. Since February 8, 2023, Immunize.org welcomed two additional healthcare organizations.
* Vybe Urgent Care Center, Bala Cynwyd, PA
* University of Michigan Health – West, Wyoming, MI
[link removed]
Eligibility:
* Eligible organizations: Hospitals, long-term care facilities, medical practices, pharmacies, professional organizations, health departments, and other government entities
* Requirements:
+ Your policy must require influenza vaccination for all staff
+ The application ([link removed]) must describe measures to prevent transmission of influenza from unvaccinated personnel to patients (e.g., masking for the entire work shift)
Related Links
* Immunize.org: List of Influenza Vaccination Honorees, all healthcare settings ([link removed]) , by state
* Immunize.org: Long-Term Care/Assisted Living Influenza Vaccination Honorees ([link removed]) by state
* Immunize.org: Influenza Vaccination Honor Roll program ([link removed]) , including:
+ Position statements ([link removed]) from professional societies and leading healthcare organizations in support of mandatory influenza vaccination
+ Application form for Influenza Vaccination Honor Roll ([link removed])
* Immunize.org: Honor Roll for Patient Safety ([link removed]) web page
Back to top (#Top)
------------------------------------------------------------
Spotlight: Immunize.org resources focused on communication between healthcare personnel and patients or caregivers
Talking about Vaccines ([link removed]) web page provides healthcare professionals with 11 topical web pages to help them discuss vaccination with concerned parents or patients. Topics include, for example, adjuvants, alternative medicine, autism, religious concerns, and thimerosal.
Unprotected People Stories ([link removed]) web page features more than 100 real-life accounts of people who suffered or died from vaccine-preventable diseases.
Handouts for Patients and Staff ([link removed]) leads to hundreds of resources that are free to download, print, copy, and distribute widely.
Vaccine Basics: Common Questions about Vaccines ([link removed]) on Immunize.org’s public website, vaccineinformation.org, offers patients and caregivers timely and accurate information about vaccines and the diseases they prevent.
Back to top (#Top)
------------------------------------------------------------
Vaccines in the news
These recent articles convey the potential risks of vaccine-preventable diseases and the importance of vaccination.
* New York Times: One Dose of HPV Vaccine Prevents Infection for at Least Three Years ([link removed]) (5/2/23)
* Washington Post: Biden Administration Tests Vaccines to Fight Avian Flu ([link removed] ) (5/2/23)
* WebMD: CDC Plans to End Community-Level COVID Reporting ([link removed]) (5/1/23)
* CBS: Biden Administration Ending Vaccine Mandate for Federal Workers and International Travelers ([link removed]) (5/1/23)
* Healio: Pediatric Vaccine Adherence Was Improving before Pandemic, but Not for Everyone ([link removed]) (4/30/23)
* Pittsburgh Post Gazette: Salk Legacy Exhibit at Pitt Displays Items Related to the Development of the Polio Vaccine ([link removed]) (4/29/23)
Back to top (#Top)
------------------------------------------------------------
Immunize.org Pages and Handouts
------------------------------------------------------------
Immunize.org updates seven translations of “Vaccinations for Preteens and Teens” and “Vaccinations for Adults”
It helps your patients when you provide vaccine information in the language your patient prefers. Seven translations of Immunize.org's handouts "Vaccinations for Preteens and Teens" and "Vaccinations for Adults" were updated and are now available for healthcare providers to print and use with patients whose preferred language is not English.
Vaccinations for Preteens and Teens ([link removed]) languages include:
* Spanish ([link removed])
* Arabic ([link removed])
* Chinese-Simplified ([link removed])
* French ([link removed])
* Korean ([link removed])
* Russian ([link removed])
* Vietnamese ([link removed])
[link removed]
Immunize.org recently updated "Vaccinations for Preteens and Teens" to categorize vaccines routinely administered in early childhood as “maybe needed”; this flags preteens and teens who may have missed out on routine vaccinations earlier in life. Also, a QR code linking to the online version of the document was added.
Vaccinations for Adults ([link removed]) languages include:
* Spanish ([link removed])
* Arabic ([link removed])
* Chinese-Simplified ([link removed])
* French ([link removed])
* Korean ([link removed])
* Russian ([link removed])
* Vietnamese ([link removed])
[link removed]
Immunize.org's most recent update to "Vaccinations for Adults" incorporates the latest vaccination recommendations for COVID-19, universal hepatitis B, new pneumococcal conjugates, and routine zoster vaccination for immunocompromised adults.
Related Links
* Immunize.org: Handouts: Adolescent Vaccination ([link removed]) main page
* Immunize.org: Parent Handouts ([link removed]) main page
* Immunize.org: Vaccination for Adults: Schedules for Patients ([link removed]) main page
* Immunize.org: Adult Vaccination ([link removed]) main page
* Immunize.org: Handouts ([link removed]) main page to see educational materials sorted by category
* Immunize.org: Educational Materials for Patients and Staff ([link removed]) —an alphabetical list of more than 230 ready-to-print staff educational materials and patient handouts
Back to top (#Top)
------------------------------------------------------------
Featured Resources
------------------------------------------------------------
NFID posts new podcast episode featuring Katherine L. O’Brien, MD, MPH, on bringing communities around the world up to date on vaccinations
Infectious IDeas ([link removed]) , a podcast series from the National Foundation for Infectious Diseases (NFID), brings leading experts together for thought-provoking conversations. The latest entry in the series, Championing Global Health Equity ([link removed]) , features Katherine L. O’Brien, MD, MPH. A description from the web page appears below.
An international leader who played a key role in shaping the global COVID-19 vaccine strategy, Katherine L. O’Brien, MD, MPH, is now focused on bringing communities around the world up to date on immunizations and creating an accord to improve the global response to the next pandemic.
[link removed]
Back to top (#Top)
------------------------------------------------------------
Voices for Vaccines releases podcast with Dorit Reiss, PhD, to discuss anti-vaccine litigation
Voices for Vaccines (VFV) posted a new entry in its Vax Talk podcast series: Anti-vaxxers Are Litigious ([link removed]) featuring Dorit Reiss, LLB, PhD. A description from the VFV web page appears below.
It feels like anti-vaxxers are bringing public health to court in droves. Does this spell the doom of people who don’t like getting measles and polio?
To explain why we shouldn’t panic and how this litigiousness works, we invite our friend Dorit Reiss, legal scholar and all-around good person.
[link removed]
Related Links
* Voices for Vaccines: Resources ([link removed]) main page
* Voices for Vaccines podcast page ([link removed])
Back to top (#Top)
------------------------------------------------------------
While supplies last! Laminated versions of CDC’s 2023 immunization schedules still available.
Immunize.org's laminated versions of the 2023 U.S. child and adolescent immunization schedule ([link removed]) and the 2023 U.S. adult immunization schedule ([link removed]) are still in stock. Once sold out, we will not print more until 2024.
While the schedules are available online from CDC at no cost, Immunize.org’s laminated schedules are ideal for use in any busy healthcare setting. Their tough coating can be wiped down, and they’re durable enough to stand up to a year of use.
* Length: Each schedule with appendices is 12 pages
* Size: Standard 8.5” X 11” booklet format
* Full Color: With color coding for easy reading, our laminated schedules replicate the original CDC formatting, including the essential tables and notes
* Bonus: The adult schedule includes Immunize.org’s popular 1-page handout summarizing the dose, route, and needle length recommendations for all vaccines and recipients
[link removed] [link removed]
Pricing for Each Schedule
$10.00: 1 copy
$ 9.50 each: 2–4 copies
$ 8.50 each: 5–19 copies
$ 7.50 each: 20–99 copies
$ 6.00 each: 100–499 copies
$ 5.00 each: 500–999 copies
$ 4.00 each: 1,000–1,999 copies
$ 3.25 each: 2,000+ copies
Visit Shop Immunize.org: Laminated Schedules ([link removed]) to view images of each page and order today!
For additional information, call 651-647-9009 or email [email protected] (mailto:[email protected]) .
Related Links
* Immunize.org: Laminated Child and Adolescent Immunization Schedules (0–18 years) ([link removed]) web page
* Immunize.org: Laminated Adult Immunization Schedules (19 and older) ([link removed]) web page
* Immunize.org: Shop Immunize.org ([link removed]) main page
* CDC: Immunization Schedules ([link removed])
Back to top (#Top)
------------------------------------------------------------
Order Immunize.org’s child, adult, and lifetime immunization record cards—wallet-sized, designed to last!
Immunize.org's personal immunization record cards ([link removed]) , printed on rip-proof, smudge-proof, water-proof paper, are designed to last a lifetime. They fit in a wallet when folded. The record cards are for you to give to your patients as a permanent personal vaccination record and are sold in boxes of 250.
* Child & Teen Immunization Record Card ([link removed])
* Adult Immunization Record Card ([link removed])
* Lifetime Immunization Record Card ([link removed])
[link removed]
Make bulk purchases and receive quantity discounts. For quotes on larger quantities or customizing, or to request sample cards, call 651-647-9009 or email [email protected] (mailto:[email protected]) .
Back to top (#Top)
------------------------------------------------------------
Notable Publications
------------------------------------------------------------
"COVID-19 Mortality Update—United States, 2022" published in MMWR
CDC published COVID-19 Mortality Update—United States, 2022 ([link removed]) on May 5 in MMWR. A portion of the summary appears below.
COVID-19 was associated with approximately 244,000 deaths in the United States during January–December 2022. . . .
The age-adjusted COVID-19 death rate declined 47% compared with 2021. As in 2020 and 2021, most COVID-19 deaths occurred in a hospital inpatient setting, but an increasing percentage occurred in the decedent’s home or a nursing home or long-term care facility. . . .
Provisional death estimates provide an early signal about shifts in COVID-19 mortality trends. Timely and actionable data can guide public health policies and interventions for populations experiencing higher COVID-19–associated mortality.
[link removed]
Access the MMWR article in HTML ([link removed]) ([link removed]) or PDF ([link removed]) .
Related Link
* MMWR's main page ([link removed]) provides access to MMWR Weekly and its companion publications
Back to top (#Top)
------------------------------------------------------------
Upcoming Events
------------------------------------------------------------
Virtual: NFID hosts webinar titled “Shingles Prevention through Vaccination” on May 17
The National Foundation of Infectious Diseases (NFID) will host a webinar titled Shingles Prevention through Vaccination ([link removed]) , 12:00–1:00 p.m. (ET) on May 17. The interactive panel will discuss the importance of herpes zoster vaccination to help prevent shingles.
There is no fee to participate in this activity, but pre-registration is required.
Register for the webinar ([link removed]) .
An on-demand recording of the webinar will be available on May 18.
Back to top (#Top)
------------------------------------------------------------
For more upcoming events, visit our Calendar of Events ([link removed]) .
Editorial Information
Editor-in-Chief
Kelly L. Moore, MD, MPH
Managing Editor
John D. Grabenstein, RPh, PhD
Associate Editor
Sharon G. Humiston, MD, MPH
Writer/Publication Coordinator
Taryn Chapman, MS
Courtnay Londo, MA
Style and Copy Editor
Marian Deegan, JD
Web Edition Managers
Arkady Shakhnovich
Jermaine Royes
Contributing Writer
Laurel H. Wood, MPA
Technical Reviewer
Kayla Ohlde
About IZ Express
Immunize.org welcomes redistribution of this issue of IZ Express or selected articles.
When you do so, please add a note that Immunize.org is the source of the material and provide a link to this issue ([link removed]) .
IZ Express is supported in part by Grant No. 1NH23IP922654 from the National Center for Immunization and Respiratory Diseases, CDC. Its contents are solely the responsibility of Immunize.org and do not necessarily represent the official views of CDC.
IZ Express Disclaimer ([link removed])
ISSN: 2771-8085
This email was sent to [email protected] (mailto:[email protected])
why did I get this? ([link removed]) unsubscribe from this list ([link removed]) update subscription preferences ([link removed])
Immunize.org . 2136 Ford Parkway . Suite 5011 . Saint Paul, MN 55116 . USA
Email not displaying correctly? View it in your browser. ([link removed])
[link removed]
Issue 1,692: May 10, 2023
Top Stories
* FDA approves first respiratory syncytial virus (RSV) vaccine for people age 60 and older; ACIP will consider recommendations for its use in future meetings (#IZX1)
* Immunize.org updates its "Checklist of Current Versions of U.S. COVID-19 Vaccination Guidance and Clinic Support Tools" (#IZX2)
* Mother’s Day is May 14; thanks to all the moms who give babies a healthy start with recommended vaccinations (#IZX3)
* 2023 Dr. Maurice R. Hilleman Essay Contest: Encourage students in grades 6–12 to enter (#IZX4)
* Immunize.org's Influenza Vaccination Honor Roll for mandatory healthcare worker vaccination now features 1,300 organizations, including two new facilities (#IZX5)
* Spotlight: Immunize.org resources focused on communication between healthcare personnel and patients or caregivers (#IZX6)
* Vaccines in the news (#IZX7)
Immunize.org Pages and Handouts
* Immunize.org updates seven translations of “Vaccinations for Preteens and Teens” and “Vaccinations for Adults” (#IZX8)
Featured Resources
* NFID posts new podcast episode featuring Katherine L. O’Brien, MD, MPH, on bringing communities around the world up to date on vaccinations (#IZX9)
* Voices for Vaccines releases podcast with Dorit Reiss, PhD, to discuss anti-vaccine litigation (#IZX10)
* While supplies last! Laminated versions of CDC’s 2023 immunization schedules still available. (#IZX11)
* Order Immunize.org’s child, adult, and lifetime immunization record cards—wallet-sized, designed to last! (#IZX12)
Notable Publications
* "COVID-19 Mortality Update—United States, 2022" published in MMWR (#IZX13)
Upcoming Events
* Virtual: NFID hosts webinar titled “Shingles Prevention through Vaccination” on May 17 (#IZX14)
Editorial Information (#Editorial)
------------------------------------------------------------
Top Stories
------------------------------------------------------------
FDA approves first respiratory syncytial virus (RSV) vaccine for people age 60 and older; ACIP will consider recommendations for its use in future meetings
According to CDC ([link removed]) , each year in the United States respiratory syncytial virus (RSV) leads to approximately 60,000–120,000 hospitalizations and 6,000–10,000 deaths among adults age 65 and older. Like influenza, RSV is a seasonal virus, with peak activity typically occurring each fall or winter. On May 30, FDA approved the first vaccine to prevent RSV, to be distributed with the brand name Arexvy (manufactured by GSK). Arexvy is approved for preventing lower respiratory tract disease (LRTD) caused by RSV in individuals age 60 and older. The next step on the vaccine’s path to clinical implementation is for CDC's Advisory Committee on Immunization Practices (ACIP) to consider recommendations for the vaccine's use at its next meeting. A portion of the FDA press release ([link removed]) appears below.
The safety and effectiveness of Arexvy is based on the FDA’s analysis of data from an ongoing, randomized, placebo-controlled clinical study conducted in the U.S. and internationally in individuals 60 years of age and older. The main clinical study of Arexvy was designed to assess the safety and effectiveness of a single dose administered to individuals 60 years of age and older. Participants will remain in the study through three RSV seasons to assess the duration of effectiveness and the safety and effectiveness of repeat vaccination. Data for a single dose of Arexvy from the first RSV season of the study were available for the FDA’s analysis. . . .
Among the participants who have received Arexvy and the participants who have received a placebo, the vaccine significantly reduced the risk of developing RSV-associated LRTD by 82.6% and reduced the risk of developing severe RSV-associated LRTD by 94.1%. . . . the most commonly reported side effects by individuals who received Arexvy were injection site pain, fatigue, muscle pain, headache and joint stiffness/pain.
Related Links
* FDA: FDA Approves First Respiratory Syncytial Virus (RSV) Vaccine ([link removed]) press release (5/3/23)
* FDA: Arexvy product approval letter ([link removed]) (5/3/23)
* FDA: Arexvy ([link removed]) web page
* FDA: Arexvy Package Insert ([link removed])
Back to top (#Top)
------------------------------------------------------------
Immunize.org updates its "Checklist of Current Versions of U.S. COVID-19 Vaccination Guidance and Clinic Support Tools"
Immunize.org reviews and updates the Checklist of Current Versions of U.S. COVID-19 Vaccination Guidance and Clinic Support Tools ([link removed]) every month, prominently indicating when it was last updated at the top of the page. In accordance with recent CDC and FDA changes to COVID-19 vaccine use and availability, the checklist has been modified as follows:
* All references to monovalent mRNA (Pfizer-BioNTech and Moderna) vaccine formulations have been removed, including all FDA and CDC materials for monovalent products
* Links to CDC clinical materials have been updated as they were available at the time of the checklist’s publication. Updates to a few clinical materials are still in process.
* Janssen COVID-19 Vaccine (Johnson & Johnson) is no longer included on the checklist. All remaining doses of this vaccine have expired.
All COVID-19 vaccination providers should review the checklist regularly. The checklist is posted on Immunize.org's Vaccines: COVID-19 ([link removed]) main page to help practices stay up to date.
[link removed]
Related Links
* Immunize.org: Checklist of Current Versions of U.S. COVID-19 Vaccination Guidance and Clinic Support Tools ([link removed]) (PDF)
* Immunize.org: Vaccines: COVID-19 ([link removed]) main page
* Immunize.org: Ask the Experts: COVID-19 ([link removed]) web page
* CDC: Interim Clinical Considerations ([link removed]) main page summarizing use of COVID-19 vaccines in the United States
Back to top (#Top)
------------------------------------------------------------
Mother’s Day is May 14; thanks to all the moms who give babies a healthy start with recommended vaccinations
Mother's Day is Sunday, May 14, this year. Immunize.org celebrates mothers and mothers-to-be and all they do to give their children a healthy start in life. Protecting babies through vaccination begins during pregnancy. Receiving influenza, Tdap, and COVID-19 vaccines during pregnancy ([link removed]) protects the mother and delivers protective antibodies through the placenta from mom to baby, providing protection through the first few months of life. CDC, the American College of Obstetrics and Gynecology ([link removed]) (ACOG) and other experts recommend these three vaccines during pregnancy.
[link removed]
Tdap is needed during each pregnancy, preferably between 27 and 36 weeks of gestation. Tdap helps protect against whooping cough (pertussis), which can be life-threatening for newborns, as well as neonatal tetanus and diphtheria.
People who get influenza or COVID-19 infections while pregnant face an increased risk of hospitalization and complications, compared to their nonpregnant peers. Getting influenza vaccine during each pregnancy helps protect mother and baby from influenza. COVID-19 vaccination should be given during pregnancy whenever it is due. Both vaccines are well-studied and safe at any stage of pregnancy. Vaccines given during pregnancy help protect mother and baby from serious complications and death.
Thank you to all the moms who work hard to safeguard the health and well-being of their children every day. Immunize.org wishes all mothers a happy Mother's Day!
Related Links
* CDC: Pregnancy and Vaccination ([link removed] ) main page
* CHOP VEC: Vaccines and Your Baby ([link removed]) booklet (view in Spanish ([link removed]) )
* Immunize.org: Handouts: Pregnancy and Vaccines ([link removed]) main page
* Immunize.org: Screening Checklists about Vaccine Contraindications and Precautions ([link removed]) main page
* Immunize.org: CDC Schedules ([link removed]) main page
Back to top (#Top)
------------------------------------------------------------
2023 Dr. Maurice R. Hilleman Essay Contest: Encourage students in grades 6–12 to enter
The Vaccine Makers Project ([link removed]) , the classroom-based program of the Vaccine Education Center (VEC) at Children’s Hospital of Philadelphia, invites submissions for the 2023 Maurice R. Hilleman Essay Contest ([link removed]) . Students in grades 6 through 12 are encouraged to learn about Dr. Hilleman’s life and accomplishments and submit a 500- to 600-word essay by June 9, 2023. This year's writing prompt is "Preparedness is an important component of science as demonstrated by Maurice Hilleman when he identified the 1957 influenza pandemic. How is preparedness critical in science today?"
This year VEC partnered with Public Health Association of British Columbia ([link removed]) , Kids Boost Immunity ([link removed]) , and Frontline Immunity ([link removed]) to open the Maurice R. Hilleman Essay Contest to Canadian students.
[link removed]
Details and the entry form are available at HillemanFilm.com/contest ([link removed]) . This year there will be three winners. The winners will each receive $500, a certificate, and recognition at a virtual award event this fall. Please share this information with eligible students or with teachers who may be interested in sharing with their students.
Related Links
* The Vaccine Makers Project ([link removed]) website
* VEC: Hilleman Film ([link removed]) website
Back to top (#Top)
------------------------------------------------------------
Immunize.org's Influenza Vaccination Honor Roll for mandatory healthcare worker vaccination now features 1,300 organizations, including two new facilities
Immunize.org's Influenza Vaccination Honor Roll ([link removed]) recognizes facilities that take a stand for patient safety by implementing policies for mandatory healthcare personnel influenza vaccination. There are now 1,300 organizations enrolled. Since February 8, 2023, Immunize.org welcomed two additional healthcare organizations.
* Vybe Urgent Care Center, Bala Cynwyd, PA
* University of Michigan Health – West, Wyoming, MI
[link removed]
Eligibility:
* Eligible organizations: Hospitals, long-term care facilities, medical practices, pharmacies, professional organizations, health departments, and other government entities
* Requirements:
+ Your policy must require influenza vaccination for all staff
+ The application ([link removed]) must describe measures to prevent transmission of influenza from unvaccinated personnel to patients (e.g., masking for the entire work shift)
Related Links
* Immunize.org: List of Influenza Vaccination Honorees, all healthcare settings ([link removed]) , by state
* Immunize.org: Long-Term Care/Assisted Living Influenza Vaccination Honorees ([link removed]) by state
* Immunize.org: Influenza Vaccination Honor Roll program ([link removed]) , including:
+ Position statements ([link removed]) from professional societies and leading healthcare organizations in support of mandatory influenza vaccination
+ Application form for Influenza Vaccination Honor Roll ([link removed])
* Immunize.org: Honor Roll for Patient Safety ([link removed]) web page
Back to top (#Top)
------------------------------------------------------------
Spotlight: Immunize.org resources focused on communication between healthcare personnel and patients or caregivers
Talking about Vaccines ([link removed]) web page provides healthcare professionals with 11 topical web pages to help them discuss vaccination with concerned parents or patients. Topics include, for example, adjuvants, alternative medicine, autism, religious concerns, and thimerosal.
Unprotected People Stories ([link removed]) web page features more than 100 real-life accounts of people who suffered or died from vaccine-preventable diseases.
Handouts for Patients and Staff ([link removed]) leads to hundreds of resources that are free to download, print, copy, and distribute widely.
Vaccine Basics: Common Questions about Vaccines ([link removed]) on Immunize.org’s public website, vaccineinformation.org, offers patients and caregivers timely and accurate information about vaccines and the diseases they prevent.
Back to top (#Top)
------------------------------------------------------------
Vaccines in the news
These recent articles convey the potential risks of vaccine-preventable diseases and the importance of vaccination.
* New York Times: One Dose of HPV Vaccine Prevents Infection for at Least Three Years ([link removed]) (5/2/23)
* Washington Post: Biden Administration Tests Vaccines to Fight Avian Flu ([link removed] ) (5/2/23)
* WebMD: CDC Plans to End Community-Level COVID Reporting ([link removed]) (5/1/23)
* CBS: Biden Administration Ending Vaccine Mandate for Federal Workers and International Travelers ([link removed]) (5/1/23)
* Healio: Pediatric Vaccine Adherence Was Improving before Pandemic, but Not for Everyone ([link removed]) (4/30/23)
* Pittsburgh Post Gazette: Salk Legacy Exhibit at Pitt Displays Items Related to the Development of the Polio Vaccine ([link removed]) (4/29/23)
Back to top (#Top)
------------------------------------------------------------
Immunize.org Pages and Handouts
------------------------------------------------------------
Immunize.org updates seven translations of “Vaccinations for Preteens and Teens” and “Vaccinations for Adults”
It helps your patients when you provide vaccine information in the language your patient prefers. Seven translations of Immunize.org's handouts "Vaccinations for Preteens and Teens" and "Vaccinations for Adults" were updated and are now available for healthcare providers to print and use with patients whose preferred language is not English.
Vaccinations for Preteens and Teens ([link removed]) languages include:
* Spanish ([link removed])
* Arabic ([link removed])
* Chinese-Simplified ([link removed])
* French ([link removed])
* Korean ([link removed])
* Russian ([link removed])
* Vietnamese ([link removed])
[link removed]
Immunize.org recently updated "Vaccinations for Preteens and Teens" to categorize vaccines routinely administered in early childhood as “maybe needed”; this flags preteens and teens who may have missed out on routine vaccinations earlier in life. Also, a QR code linking to the online version of the document was added.
Vaccinations for Adults ([link removed]) languages include:
* Spanish ([link removed])
* Arabic ([link removed])
* Chinese-Simplified ([link removed])
* French ([link removed])
* Korean ([link removed])
* Russian ([link removed])
* Vietnamese ([link removed])
[link removed]
Immunize.org's most recent update to "Vaccinations for Adults" incorporates the latest vaccination recommendations for COVID-19, universal hepatitis B, new pneumococcal conjugates, and routine zoster vaccination for immunocompromised adults.
Related Links
* Immunize.org: Handouts: Adolescent Vaccination ([link removed]) main page
* Immunize.org: Parent Handouts ([link removed]) main page
* Immunize.org: Vaccination for Adults: Schedules for Patients ([link removed]) main page
* Immunize.org: Adult Vaccination ([link removed]) main page
* Immunize.org: Handouts ([link removed]) main page to see educational materials sorted by category
* Immunize.org: Educational Materials for Patients and Staff ([link removed]) —an alphabetical list of more than 230 ready-to-print staff educational materials and patient handouts
Back to top (#Top)
------------------------------------------------------------
Featured Resources
------------------------------------------------------------
NFID posts new podcast episode featuring Katherine L. O’Brien, MD, MPH, on bringing communities around the world up to date on vaccinations
Infectious IDeas ([link removed]) , a podcast series from the National Foundation for Infectious Diseases (NFID), brings leading experts together for thought-provoking conversations. The latest entry in the series, Championing Global Health Equity ([link removed]) , features Katherine L. O’Brien, MD, MPH. A description from the web page appears below.
An international leader who played a key role in shaping the global COVID-19 vaccine strategy, Katherine L. O’Brien, MD, MPH, is now focused on bringing communities around the world up to date on immunizations and creating an accord to improve the global response to the next pandemic.
[link removed]
Back to top (#Top)
------------------------------------------------------------
Voices for Vaccines releases podcast with Dorit Reiss, PhD, to discuss anti-vaccine litigation
Voices for Vaccines (VFV) posted a new entry in its Vax Talk podcast series: Anti-vaxxers Are Litigious ([link removed]) featuring Dorit Reiss, LLB, PhD. A description from the VFV web page appears below.
It feels like anti-vaxxers are bringing public health to court in droves. Does this spell the doom of people who don’t like getting measles and polio?
To explain why we shouldn’t panic and how this litigiousness works, we invite our friend Dorit Reiss, legal scholar and all-around good person.
[link removed]
Related Links
* Voices for Vaccines: Resources ([link removed]) main page
* Voices for Vaccines podcast page ([link removed])
Back to top (#Top)
------------------------------------------------------------
While supplies last! Laminated versions of CDC’s 2023 immunization schedules still available.
Immunize.org's laminated versions of the 2023 U.S. child and adolescent immunization schedule ([link removed]) and the 2023 U.S. adult immunization schedule ([link removed]) are still in stock. Once sold out, we will not print more until 2024.
While the schedules are available online from CDC at no cost, Immunize.org’s laminated schedules are ideal for use in any busy healthcare setting. Their tough coating can be wiped down, and they’re durable enough to stand up to a year of use.
* Length: Each schedule with appendices is 12 pages
* Size: Standard 8.5” X 11” booklet format
* Full Color: With color coding for easy reading, our laminated schedules replicate the original CDC formatting, including the essential tables and notes
* Bonus: The adult schedule includes Immunize.org’s popular 1-page handout summarizing the dose, route, and needle length recommendations for all vaccines and recipients
[link removed] [link removed]
Pricing for Each Schedule
$10.00: 1 copy
$ 9.50 each: 2–4 copies
$ 8.50 each: 5–19 copies
$ 7.50 each: 20–99 copies
$ 6.00 each: 100–499 copies
$ 5.00 each: 500–999 copies
$ 4.00 each: 1,000–1,999 copies
$ 3.25 each: 2,000+ copies
Visit Shop Immunize.org: Laminated Schedules ([link removed]) to view images of each page and order today!
For additional information, call 651-647-9009 or email [email protected] (mailto:[email protected]) .
Related Links
* Immunize.org: Laminated Child and Adolescent Immunization Schedules (0–18 years) ([link removed]) web page
* Immunize.org: Laminated Adult Immunization Schedules (19 and older) ([link removed]) web page
* Immunize.org: Shop Immunize.org ([link removed]) main page
* CDC: Immunization Schedules ([link removed])
Back to top (#Top)
------------------------------------------------------------
Order Immunize.org’s child, adult, and lifetime immunization record cards—wallet-sized, designed to last!
Immunize.org's personal immunization record cards ([link removed]) , printed on rip-proof, smudge-proof, water-proof paper, are designed to last a lifetime. They fit in a wallet when folded. The record cards are for you to give to your patients as a permanent personal vaccination record and are sold in boxes of 250.
* Child & Teen Immunization Record Card ([link removed])
* Adult Immunization Record Card ([link removed])
* Lifetime Immunization Record Card ([link removed])
[link removed]
Make bulk purchases and receive quantity discounts. For quotes on larger quantities or customizing, or to request sample cards, call 651-647-9009 or email [email protected] (mailto:[email protected]) .
Back to top (#Top)
------------------------------------------------------------
Notable Publications
------------------------------------------------------------
"COVID-19 Mortality Update—United States, 2022" published in MMWR
CDC published COVID-19 Mortality Update—United States, 2022 ([link removed]) on May 5 in MMWR. A portion of the summary appears below.
COVID-19 was associated with approximately 244,000 deaths in the United States during January–December 2022. . . .
The age-adjusted COVID-19 death rate declined 47% compared with 2021. As in 2020 and 2021, most COVID-19 deaths occurred in a hospital inpatient setting, but an increasing percentage occurred in the decedent’s home or a nursing home or long-term care facility. . . .
Provisional death estimates provide an early signal about shifts in COVID-19 mortality trends. Timely and actionable data can guide public health policies and interventions for populations experiencing higher COVID-19–associated mortality.
[link removed]
Access the MMWR article in HTML ([link removed]) ([link removed]) or PDF ([link removed]) .
Related Link
* MMWR's main page ([link removed]) provides access to MMWR Weekly and its companion publications
Back to top (#Top)
------------------------------------------------------------
Upcoming Events
------------------------------------------------------------
Virtual: NFID hosts webinar titled “Shingles Prevention through Vaccination” on May 17
The National Foundation of Infectious Diseases (NFID) will host a webinar titled Shingles Prevention through Vaccination ([link removed]) , 12:00–1:00 p.m. (ET) on May 17. The interactive panel will discuss the importance of herpes zoster vaccination to help prevent shingles.
There is no fee to participate in this activity, but pre-registration is required.
Register for the webinar ([link removed]) .
An on-demand recording of the webinar will be available on May 18.
Back to top (#Top)
------------------------------------------------------------
For more upcoming events, visit our Calendar of Events ([link removed]) .
Editorial Information
Editor-in-Chief
Kelly L. Moore, MD, MPH
Managing Editor
John D. Grabenstein, RPh, PhD
Associate Editor
Sharon G. Humiston, MD, MPH
Writer/Publication Coordinator
Taryn Chapman, MS
Courtnay Londo, MA
Style and Copy Editor
Marian Deegan, JD
Web Edition Managers
Arkady Shakhnovich
Jermaine Royes
Contributing Writer
Laurel H. Wood, MPA
Technical Reviewer
Kayla Ohlde
About IZ Express
Immunize.org welcomes redistribution of this issue of IZ Express or selected articles.
When you do so, please add a note that Immunize.org is the source of the material and provide a link to this issue ([link removed]) .
IZ Express is supported in part by Grant No. 1NH23IP922654 from the National Center for Immunization and Respiratory Diseases, CDC. Its contents are solely the responsibility of Immunize.org and do not necessarily represent the official views of CDC.
IZ Express Disclaimer ([link removed])
ISSN: 2771-8085
This email was sent to [email protected] (mailto:[email protected])
why did I get this? ([link removed]) unsubscribe from this list ([link removed]) update subscription preferences ([link removed])
Immunize.org . 2136 Ford Parkway . Suite 5011 . Saint Paul, MN 55116 . USA
Message Analysis
- Sender: Immunization Action Coalition
- Political Party: n/a
- Country: United States
- State/Locality: n/a
- Office: n/a
-
Email Providers:
- MailChimp